Rockwell Automation CEO Executes Option Exercise and 10b5-1 Sale
Rhea-AI Filing Summary
Blake D. Moret, President and CEO and a director of Rockwell Automation (ROK), reported transactions dated 09/11/2025. He exercised 24,400 employee stock options with an exercise price of $115.89 and acquired 24,400 common shares. The same day 24,400 shares were sold under a Rule 10b5-1 trading plan entered 05/30/2025 at a weighted average price of $350.131 per share. Following the reported transactions his total beneficial ownership is reported as 108,273 shares in one line and 83,873 shares in the sale line; additional holdings include Company stock fund units noted from the Savings Plan as reported by the Plan Administrator.
Positive
- Transaction executed under a Rule 10b5-1 plan, which provides an affirmative defense and indicates pre-planned timing
- Full Form 4 disclosure provided including option exercise details, weighted average sale price, and explanatory remarks
Negative
- None.
Insights
TL;DR: Routine option exercise and concurrent sale under a pre-established 10b5-1 plan; no new material corporate information disclosed.
The filing shows a common pattern where an executive exercises vested options and sells an equal number of shares the same day under a 10b5-1 plan, realizing the spread between the exercise price ($115.89) and the sale proceeds (weighted average $350.131). This transaction crystallizes economic gain from long-dated compensation but does not by itself change control or indicate material operational news. Reported beneficial ownership figures and plan disclosure comply with Section 16 reporting norms.
TL;DR: Proper disclosure of exercise and Rule 10b5-1 sale; procedural governance appears consistent with insider trading policies.
The Form 4 documents an exercise of employee options granted earlier (exercise price $115.89, original grant date shown as 07/01/2017) and an immediate sale under a trading plan entered 05/30/2025. The filing includes the required explanatory note about the 10b5-1 plan and weighted average sale price, and is signed by an attorney-in-fact. From a governance perspective, the presence of a documented trading plan and the explanatory disclosures reduce concerns about opportunistic insider sales, and the submission appears procedurally sound.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 24,400 | $0.00 | -- |
| Exercise | Common Stock | 24,400 | $0.00 | -- |
| Sale | Common Stock | 24,400 | $350.131 | $8.54M |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Shares exercised and sold pursuant to a Rule 10b5-1 trading plan entered into on 5/30/2025. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $350 to $350.58. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price. Includes shares represented by Company stock fund units acquired under the Company Savings Plan since the date last reported for this person based on information furnished by the Plan Administrator as of 9/3/2025. The number of stock fund units represented by the balance of the participant's Company stock fund account may not exactly equal the number of stock fund units represented by a prior balance due to variance in the proportion of uninvested cash held in the reference fund used to determine unit values of the Company stock fund under the Plan.
